<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783925/" ref="ordinalpos=1107&amp;ncbi_uid=2595301&amp;link_uid=PMC2783925" image-link="/pmc/articles/PMC2783925/figure/F4/" class="imagepopup">Figure 4. Analysis of RAS and PI3-Kinase <span class="highlight" style="background-color:">pathway</span> activation signatures.  From: Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3-Kinase <span class="highlight" style="background-color:">pathway</span> activation. </a></div><br /><div class="p4l_captionBody">Gene expression signatures of oncogenic signaling pathways to characterize the activation status of RAS and PI3-kinase pathways were applied to data from patients with PV and healthy controls. The probability of PI3-kinase (panels on left) and RAS pathway (panels on right) deregulation in PV erythroblasts are significantly increased compared to normal control erythroblasts.</div></div>